$4.74
3.04%
Nasdaq, Aug 22, 10:00 pm CET
ISIN
CA74319B5027
Symbol
PROF

Profound Medical Corp Stock price

$4.74
-1.13 19.25% 1M
-2.70 36.29% 6M
-2.77 36.88% YTD
-4.57 49.09% 1Y
-2.72 36.46% 3Y
-9.71 67.20% 5Y
-5.45 53.46% 10Y
-5.45 53.46% 20Y
Nasdaq, Closing price Fri, Aug 22 2025
+0.14 3.04%

Key metrics

Basic
Market capitalization
$142.0m
Enterprise Value
$111.7m
Net debt
positive
Cash
$35.2m
Shares outstanding
30.1m
Valuation (TTM | estimate)
P/E
negative | negative
P/S
12.0 | 8.1
EV/Sales
9.4 | 6.4
EV/FCF
negative
P/B
3.6
Financial Health
Equity Ratio
86.0%
Return on Equity
-46.0%
ROCE
-96.3%
ROIC
-330.2%
Debt/Equity
0.1
Financials (TTM | estimate)
Revenue
$11.8m | $17.5m
EBITDA
$-41.6m | $-38.6m
EBIT
$-42.3m | $-40.3m
Net Income
$-40.7m | $-33.7m
Free Cash Flow
$-34.7m
Growth (TTM | estimate)
Revenue
50.3% | 64.0%
EBITDA
-40.4% | -20.0%
EBIT
-38.0% | -22.1%
Net Income
-47.6% | -21.1%
Free Cash Flow
-57.2%
Margin (TTM | estimate)
Gross
69.4%
EBITDA
-351.0% | -220.1%
EBIT
-357.4%
Net
-344.0% | -192.4%
Free Cash Flow
-293.3%
More
EPS
$-1.4
FCF per Share
$-1.2
Short interest
2.6%
Employees
142
Rev per Employee
$80.0k
Show more

Is Profound Medical Corp a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,015 stocks worldwide.

Profound Medical Corp Stock Analysis

Unlock Scores for Free

Analyst Opinions

6 Analysts have issued a Profound Medical Corp forecast:

5x Buy
83%
1x Hold
17%

Analyst Opinions

6 Analysts have issued a Profound Medical Corp forecast:

Buy
83%
Hold
17%

Financial data from Profound Medical Corp

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
12 12
50% 50%
100%
- Direct Costs 3.62 3.62
18% 18%
31%
8.22 8.22
71% 71%
69%
- Selling and Administrative Expenses 31 31
54% 54%
260%
- Research and Development Expense 20 20
27% 27%
167%
-42 -42
40% 40%
-351%
- Depreciation and Amortization 0.76 0.76
29% 29%
6%
EBIT (Operating Income) EBIT -42 -42
38% 38%
-357%
Net Profit -41 -41
48% 48%
-344%

In millions USD.

Don't miss a Thing! We will send you all news about Profound Medical Corp directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Profound Medical Corp Stock News

Negative
Seeking Alpha
6 days ago
I am initiating Profound Medical Corp. at a Sell rating with a fair value of $2.9 per share due to financial concerns. TULSA-PRO shows promise for BPH and localized prostate cancer, but long-term efficacy and sales growth remain uncertain. Heavy reliance on share issuance, high SBC relative to revenue, and ongoing negative cash flow raise significant balance sheet risks.
Neutral
Seeking Alpha
10 days ago
Profound Medical Corp. (NASDAQ:PROF ) Q2 2025 Earnings Conference Call August 14, 2025 4:30 PM ET Company Participants Arun Swarup Menawat - Chairman of the Board & CEO Mathieu Burtnyk - President Rashed Dewan - Chief Financial Officer Stephen Kilmer - Corporate Participant Investor Relations - Corporate Participant Thomas Tamberrino - Chief Commercial Officer Conference Call Participants Benja...
Neutral
GlobeNewsWire
10 days ago
TORONTO, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of diseased tissue, today reported unaudited financial results for the second quarter ended June 30, 2025. Unless specified otherwise, all amo...
More Profound Medical Corp News

Company Profile

Profound Medical Corp. develops, manufactures and markets therapeutic platforms that combine real-time magnetic resonance imaging with directional and focused ultrasound technology for incision-free ablation of diseased tissue. Its platforms offer clinicians and patients incision-free alternatives to current standards of care which could include traditional surgery or radiation therapy. Its products include TULSA-PRO and Sonalleve. The company was founded in 2008 and is headquartered in Mississauga, CA.

Head office Canada
CEO Arun Menawat
Employees 142
Founded 2008
Website profoundmedical.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today